1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
CRI Career Development Awards is a collection of funding programs from the Cancer Research Institute (CRI) that supports scientists at every career stage advancing cancer immunology and immunotherapy research.
Programs include the CRI Irvington Postdoctoral Fellowship for early-career scientists, the CRI Immuno-Informatics Postdoctoral Fellowship for researchers at the intersection of immunology and data science, CLIP grants supporting the transition to independent tenure-track positions, and the CRI Lloyd J. Old STAR Program for mid-career scientists pursuing high-risk, high-reward research.
Additional awards include the CRI Clinic and Laboratory Integration Program (CLIP), the CRI Technology Impact Award for pre-development concepts, and clinical trial support grants. Eligible applicants are scientists at academic research institutions focused on cancer immunotherapy.
Get alerted about grants like this
Save a search for “Cancer Research Institute (CRI)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Apply for Grants | Cancer Research Institute Apply for Grants | Cancer Research Institute Grant funding to advance careers and transform cancer care Career Development Awards CRI Irvington Postdoctoral Fellowship Training the Next Generation of Leaders in Immunology and Cancer Research Supports early-career scientists with mentorship, training, and resources to launch independent research in immunology and cancer immunology CRI Immuno-Informatics Postdoctoral Fellowship Cultivating the Next Generation of Leaders at the Intersection of Immunology and Data Science Supports outstanding early-career scientists who seek dual expertise in immunology and data science Inspiring Growth and Nurturing Independence Through Excellence Supports the transition of distinguished postdoctoral researchers into independent tenure-track investigators CRI Lloyd J.
Old STAR Program Empowering Bold Thinkers to Transform Cancer Immunotherapy Supports mid-career scientists pursuing high-risk, high-reward research at the leading edge of cancer immunotherapy Translational Innovation and Clinical Impact Awards CRI Clinic and Laboratory Integration Program Accelerating the Translation of Immunological Discoveries into Cancer Therapies Supports innovative investigations at the intersection of laboratory discovery and clinical application in cancer immunology CRI Technology Impact Award Turning Bold Visions into Breakthroughs in Cancer Immunotherapy Supports early-stage, pre-development concepts that hold the potential to transform the landscape of cancer immunotherapy Advancing Breakthrough Immunotherapy Trials to Transform Patient Care Supports pioneering immunotherapy clinical trials designed and led by academic researchers Protocol Concept Deadline These current and future scientific leaders in immunology and tumor immunology, from top academic research institutions, are advancing fundamental and applied discoveries that impact cancer research.
From bench to bedside, CRI is ushering in the next generation of cancer immunotherapy innovations. CRI recognizes research pioneers that drive major advances in immunology and cancer immunotherapy.
Based on current listing details, eligibility includes: Scientists at every career stage focusing on cancer immunotherapy research. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Varies Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
NBNA Scholarship Program is a grant from National Black Nurses Association (NBNA) providing scholarships starting at $1,000 to nursing students at all levels, from LPN to Doctorate. Open to active NBNA members currently enrolled in accredited nursing programs with at least one year of schooling remaining. Over 32 scholarships totaling more than $68,000 were awarded in 2020, and over $150,000 has been distributed to PhD candidates to date. Awards are presented annually at the NBNA Institute and Conference. The 2025-2026 program cycle is currently open. Applicants must be members of a local NBNA chapter.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.